IPG
Ipd Group Ltd
🇦🇺 ASX
🔨 COMMERCIAL SERVICES & SUPPLIES
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 115.30%
Annual Growth
3 years average annual growth
💰
2.02%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
41
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
IPD Group Ltd. engages in the servicing industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-12-17. The firm's Products division is engaged in the sale of electrical infrastructure products to customers, including switchboard manufacturers, electrical wholesalers, electrical contractors, power utilities, original equipment manufacturers (OEMs) and system integrators. Within the division there are five categories of products: power distribution, industrial and motor control, automation and industrial communication, power monitoring, and hazardous area equipment. In addition to selling products, it provides a range of value-added services, including custom assembly, sourcing, engineering design, technical compliance, procurement, transport, storage, regulatory management, technical support, packaging, labelling, inventory management and delivery. Its Services division is engaged in provision of services, including installation and commissioning, calibration and testing, maintenance, and repairs, and others.
📈 Performance
Price History
+318.33%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
2.02%
💰 Annual Dividend Earnings Per $1,000 invested**
$20.17
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
100.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of IPG, your last dividend payment(s) would have been:
$ 143.17
on Wed Apr 10 2024
$ 142.25
on Tue Oct 03 2023
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.09
100.00%
2022
$0.04
100.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
2015
$0.00
0.00%
💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$5.02
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IPG
41
📊 Total Capital Earnings
$70K
🔃 Average investment frequency
26 weeks
💵 Average investment amount
$3,192
⏰ Last time a customer invested in IPG
9 days
IPG investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
14%
50k - 100k
37%
Less than 50k
33%
👶 Age of investors
18 - 25
10%
26 - 34
27%
35 - 90
63%
🙋 Legal gender of investors
Female
32%
Male
68%
Pearlers who invest in IPG also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.76%
📊 Share price
$102.49 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
17.56%
📊 Share price
$55.75 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
23.53%
📊 Share price
$42.92 AUD
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
🇺🇸 UNITED STATES
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
🙌 Performance (5Yr p.a)
4.22%
📊 Share price
$138.20 AUD
💸 FINANCIALS
⛳️ DIVERSIFIED
🇦🇺 AUSTRALIA
RMD
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,140 full-time employees. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.
🙌 Performance (5Yr p.a)
16.17%
📊 Share price
$35.23 AUD
🕊️ SOCIALLY AWARE
📈 HIGH PRICE GROWTH
🌳 ENVIRONMENTAL
🩺 HEALTH CARE
Want more shares? Try these...
IPH
IPH Ltd. is a holding company, which engages in the provision of intellectual property services. The company is headquartered in Sydney, New South Wales and currently employs 1,300 full-time employees. The company went IPO on 2014-11-19. The firm provides services for the protection, commercialization, enforcement, and management of all forms of IP including patents, trademarks, and designs. The company operates through four segments: Intellectual Property Services Australia & New Zealand; Intellectual Property Services Asia; Intellectual Property Services Canada; and Adjacent Businesses. The segments offer services related to the provision of filing, prosecution, enforcement and management of patents, designs, trademarks and other IP. Its Adjacent Businesses include the operations of Wisetime. The firm operates in approximately 10 IP jurisdictions, servicing clients in more than 25 countries globally. The firm offers a range of IP services and products to a diverse client base including companies, multinationals, public sector research organizations, small and medium-sized enterprises (SMEs), and professional services firms.
🙌 Performance (5Yr p.a)
-6.49%
📊 Share price
$5.93 AUD
👔 PROFESSIONAL SERVICES
Incitec Pivot Ltd. engages in manufacturing and selling of explosives, fertilisers and industrial chemicals. The company is headquartered in Southbank, Victoria and currently employs 5,800 full-time employees. The company went IPO on 2003-07-28. Its segments include Asia Pacific and Americas. Asia Pacific segment includes Fertilisers Asia Pacific (Fertilisers APAC) and Dyno Nobel Asia Pacific (DNAP). Fertilisers APAC manufactures and sells fertilizers in Eastern Australia and the export market. The company also manufactures, imports and sells industrial chemicals to the agricultural sector and other specialist industries. DNAP manufactures and sells industrial explosives and related products and services to the mining industry in the Asia Pacific region, Turkey and France. Americas segment includes Dyno Nobel Americas, which manufactures and sells industrial explosives and related products and services to the mining, quarrying and construction industries in the Americas (Canada, Mexico and Chile) and initiating systems to businesses in Australia, Turkey and South Africa. The company also manufactures and sells industrial chemicals.
🙌 Performance (5Yr p.a)
-1.96%
📊 Share price
$3.13 AUD
🧪 CHEMICALS
Imperial Pacific Ltd. engages in the business of strategic equity investment in financial services. The principal activities of the Company include strategic equity investment in financial services and the portfolio management of London City Equities Limited. The company provides productive management input to related parties in which it has a strategic equity interest. The firm's subsidiaries include Imperial Pacific Asset Management Pty Ltd and Imperial Pacific Fund Managers Pty Ltd.
🙌 Performance (5Yr p.a)
5.25%
📊 Share price
$1.35 AUD
💸 FINANCIALS
💰 HIGH DIVIDEND
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 76 full-time employees. The company went IPO on 2007-10-24. The firm uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The firm designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.
🙌 Performance (5Yr p.a)
-14.08%
📊 Share price
$0.05 AUD
🩺 HEALTH CARE